Sort
48,018 grants matching “immunotherapy”
Analysis of Fel d 1-specific T cells after airway allergen challenge in asthma
$522,225Gail M Gauvreau · Mcmaster University · U19 · FY2012 · AI
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC
$522,215Judith A. Varner · University Of California, San Diego · R01 · FY2024 · CA
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC
$522,215Judith A. Varner · University Of California, San Diego · R01 · FY2025 · CA
Molecular Immunology and Tumor Biology
$522,182David Michael Langenau · Massachusetts General Hospital · T32 · FY2024 · CA
Rare Central Nervous System Cancers Initiative
$522,109Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Translational Immunology
$522,109Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Regulation of JAK/STAT pathways in the eye
$522,010Charles E Egwuagu · National Eye Institute · ZIA · FY2025 · EY
Evolutionary Models of the Immune System
$521,979Melvin Cohn · Salk Institute For Biological Studies · R01 · FY2009 · RR
Overcoming obesity-associated immunotherapy resistance in renal cancer
$521,969Lyse A Norian · University Of Alabama At Birmingham · R01 · FY2025 · CA
Focal segmental glomerulosclerosis: Treatment
$521,910Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
$521,890Chad A. Mirkin · Northwestern University · R01 · FY2022 · CA
TRAINING GRANT IN MOLECUCLAR IMAGING RESEARCH AND CANCER SYSTEMS ANALYSIS
$521,885Ralph Weissleder · Massachusetts General Hospital · T32 · FY2021 · CA
A HER-2/neu pulsed DC1 vaccine for patients with DCIS
$521,861Brian Joseph Czerniecki · University Of Pennsylvania · R01 · FY2009 · CA
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.
$521,831Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.
$521,831Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Molecular Basis of CD1D and Natural Killer T Cell Function
$521,826Sebastian Joyce · Vanderbilt University Medical Center · R01 · FY2020 · AI
Intratumoral Cytokine Immunotherapy Studies in Companion Canine Cancer Models
$521,821Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2022 · CA
Enhancing the Potency and Durability of Immunotherapies
$521,774Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2018 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$521,765Philip D Greenberg · University Of Washington · R01 · FY2014 · CA
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
$521,582Bin Zhang · Northwestern University At Chicago · R01 · FY2022 · CA
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab
$521,566Edith A Perez · Mayo Clinic Jacksonville · R01 · FY2014 · CA
Radioluminescence dosimetry solution for precision radiation therapy
$521,555Lei Xing · Stanford University · R01 · FY2018 · CA
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$521,546Justin M Balko · Vanderbilt University Medical Center · R01 · FY2020 · CA
Molecular Genetics
$521,506Carlo M Croce · University Of California, San Diego · P01 · FY2013 · CA
Molecular Basis of Parvoviral Target Cell Specificity
$521,493Peter Tattersall · Yale University · R01 · FY2010 · CA